DESTINY-PANTUMOUR04

Trial Identifier:	D781WR00001
Sponsor:	AstraZeneca
Start Date:	August 2025
Primary Completion Date:	February 2028
Study Completion Date:	February 2028
Condition:	Bladder Cancer; Cancer - Other; Endometrial Cancer; Esophageal cancer; Head and Neck Cancer; Liver Cancer; Skin Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer; Lung Cancer; Testicular Cancer; Thyroid Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.